IHM
ARRY

Iguana Healthcare Management’s Array Biopharma Inc ARRY Stock Holding History

Iguana Healthcare Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100,000
Closed -$879K – 84
2016
Q4 		$879K Sell
100,000
-300,000
-75% -$2.21M 0.53% 46
2016
Q3 		$2.7M Buy
+400,000
New +$1.55M 0.48% 58
2014
Q1 		– Sell
-200,000
Closed -$1M – 99
2013
Q4 		$1M Buy
+200,000
New +$1.09M 0.57% 51

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Iguana Healthcare Management's ARRY Position: Q1 2017 in Review

Iguana Healthcare Management sold out of Array Biopharma Inc (ARRY) in Q1 2017, closing a stake of 100,000 shares — an estimated $879K sold.

Iguana Healthcare Management first reported a position in ARRY in Q4 2013 and held it in 3 quarters. The position peaked at $2.7M in Q3 2016. 187 funds tracked by Wall St. Rank hold ARRY as of Q1 2017.

  • Iguana Healthcare Management reported no remaining Array Biopharma Inc position as of Q1 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 100,000 Array Biopharma Inc shares in Q1 2017, an estimated $879K.
  • Iguana Healthcare Management first reported a position in Array Biopharma Inc in Q4 2013 and held it in 3 quarters.
  • Iguana Healthcare Management's Array Biopharma Inc position peaked at $2.7M in Q3 2016.
  • 187 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2017.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.